Business, cardiology

Biosense Webster and Medtronic to jointly develop cardiac arrhythmia care

16 May 2007

Diamond Bar, Calif. & Minneapolis, USA. Biosense Webster, Inc. and Medtronic, Inc. (NYSE:MDT), have announced plans to collaborate to advance the care of patients with cardiac arrhythmias, also known as irregular heartbeats.

Under the terms of the agreement, the two companies plan to collaborate on three key areas of interest: a clinical trial, a technology development initiative and educational programs. The companies intend to design the clinical trial to create a new care pathway for identifying candidates most likely to have a successful ablation treatment outcome and increase the acceptance of ablation therapy.

In addition, the two companies will work together to advance patient care through a joint research and development program. The companies plan to integrate specific technologies to provide novel, new solutions for the treatment of complex cardiac arrhythmias.

“We are pleased to collaborate with Medtronic in this important endeavor,” said Roy Tanaka, President, Biosense Webster, Inc. “This new strategic alliance will leverage the unique resources and technologies of the two companies together, and will benefit the millions of patients who suffer from cardiac arrhythmias around the world.”

“Medtronic is intently focused on researching and exploring ways to utilize existing or new technologies for electrophysiologists to better identify and treat patients with cardiac arrhythmias,” said Steve Mahle, President of Medtronic’s Cardiac Rhythm Disease Management business. “This collaboration will begin by bringing the unique competencies of imaging and navigation together with diagnostics and monitoring in an effort to improve the electrophysiologist’s capability in identifying and treating patients. We look forward to collaborating with Biosense Webster to deliver exciting results for our customers.”

“With Biosense Webster, we can continue our commitment to education of physicians at all stages of their career,” said Mahle. “The field of electrophysiology is always changing and advancing and it is vital that physicians and other health care professionals who work in this field are up-to-date on the latest technologies designed to help patients.”

To top

To top